COVID-19 and SARS-CoV-2

Active
Clinical trials

Active
Development and evaluation of rapid point of care diagnostics

Active
Emerging and Re-Emerging Infectious Diseases with epidemic potential

Active
Evaluation and development of newer TB diagnostics in HIV-infected children and adults with TB
Host-Directed Therapies

Active
Infectious diseases
Microorganisms and immunoregulation

Active
Molecular diagnostics

Active
Optimal timing of HAART therapy in HIV-i etc
Pathogenesis and autopsy studies

Active
R&D in poverty related killer diseases TB, HV/AIDS

Active
Rapid diagnostics for endocarditis
Zoonotic infections

Active